Close-up of colorful glass bubbles with reflections and tiny air bubbles inside, set against a dark background.
An abstract digital image featuring a spherical object with bright orange and yellow hues against a black background, with additional circular elements overlapping the sphere.

CLEANOilCell™

The next generation of sustainable oil production

CLEANOil™

Gradient color bar transitioning from green on the left to red on the right.

One Platform, One Process

CLEANFat™

Scalable, cost-efficient , capital-light platform

Magnifying glass with virus or bacteria symbol inside, representing virus detection or analysis.

10 years of research to develop proprietary oleaginous yeast strains and fermentation process

Icon of a light bulb with a lock inside, symbolizing ideas or innovation related to security or protection.

• Non GM
• Can use wide range of C5/C6 sugars
• Retro-fit infrastructure

A globe with a heart in the center, outlined in orange on a black background.

Over 90% reduction in C02 emissions vs. agricultural alternatives

Clean Food Group’s proprietary CLEANOilCell™ technology platform uses proven, scalable, non-GMO yeast strains and food waste as its food source, to deliver sustainable alternatives to traditional oil and fat ingredients.

The robust technology platform has been developed as a result of 10 years of pioneering research into the development of proprietary oleaginous yeast strains and fermentation processes, built on over £7.5 million of UK Government funding.

FIND OUT MORE ABOUT

Industrial fermentation tanks with overlay text 'Precision Fermentation' and a triangle play button in the center.
“We’ve got a really robust yeast that is capable of growing in low-sterile conditions, so we can retrofit existing fermentation units- we don’t have to go out and build new bioreactors. This dramatically decreases capex and lead time to scale to market. This is a big point of differentiation compared to our competitors who are using less robust yeast, or genetically modified organisms, which means they require pharmaceutical style, purpose built bioreactors”
— Tom Ellen, CFO